Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2005
11/03/2005US20050245546 e.g. cyclopentyl(9-ethyl-8-phenylpurin-6-yl)amine; diuretic; heart failure, chronic renal disease, cirrhosis
11/03/2005US20050245545 administering a xanthine derivative such as (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine
11/03/2005US20050245544 Novel pharmaceuticals
11/03/2005US20050245543 Histamine-3 receptor antagonists
11/03/2005US20050245542 Pyridazine, pyrimidine and pyrazine ethyne compounds
11/03/2005US20050245541 Methods for treating alcoholism
11/03/2005US20050245540 New methods
11/03/2005US20050245539 Female sexual disorders; combination therapy
11/03/2005US20050245537 Use of compounds having ccr antagonism
11/03/2005US20050245536 N-Pyridyl-7-substituted-2-indolecarboxamides, e.g., 1-Methyl-7-[2-(4-methyl-piperazin-1-yl)-pyrimidin-4-yloxy]-1H-indole-2-carboxylic acid (2-tert-butyl-5-methoxy-pyridin-4-yl)-amide; used to treat chronic inflammatory diseases
11/03/2005US20050245535 Sulfonyl amide inhibitors of calcium channel function
11/03/2005US20050245533 Inhibitors of the 11-beta-hydroxysteroid dehydrogenaseType 1 enzyme and their therapeutic application
11/03/2005US20050245532 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their therapeutic application
11/03/2005US20050245530 Monocyclic heterocycles as kinase inhibitors
11/03/2005US20050245529 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
11/03/2005US20050245527 Nitrogen containing heterocyclic compounds and medicines containing the same
11/03/2005US20050245525 Compounds useful for inhibiting CHK1
11/03/2005US20050245524 Benzotriazine inhibitors of kinases
11/03/2005US20050245523 Heteroaryl derivatives and their use as medicaments
11/03/2005US20050245522 Novel compounds
11/03/2005US20050245521 3-[-2-(Piperazin-1-yl)benzyl]pyrrolidin-2-one derivatives; antidepressants, anxiolytic agents; obsessive compulsive disorder, psychological disorders, phobias; 5-HT1 agonist or antagonists; side effect reduction, in particular cardiac QTc prolongation; hydrogenation
11/03/2005US20050245520 2-Phenylpyridin-4-yl derivatives as alk5 inhibitors
11/03/2005US20050245519 Substituted morpholine compounds for the treatment of central nervous system disorders
11/03/2005US20050245518 Inhibitors of histone deacetylase
11/03/2005US20050245517 2-pyridinyl[7-(substituted-pyridin-4-yl) pyrazolo[1,5-a]pyrimidin-3-yl]methanones
11/03/2005US20050245513 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
11/03/2005US20050245512 Method and composition for rejuvinating cells, tissues organs, hair and nails
11/03/2005US20050245511 Novel compounds that inhibit tryptase activity
11/03/2005US20050245510 Use of meloxicam formulations in veterinary medicine
11/03/2005US20050245509 Remedy for glaucoma comprising rho kinase inhibitor and prostaglandins
11/03/2005US20050245508 Treatment of malignant gliomas with TGF-beta inhibitors
11/03/2005US20050245507 7-Phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents
11/03/2005US20050245506 Treatment of congestive heart failure
11/03/2005US20050245505 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as antibacterial agents
11/03/2005US20050245504 Treatment of diseases with combinations of alpha 7 Nicotinic Acetylcholine Receptor agonists and other compounds
11/03/2005US20050245503 Therapeutic heterocycles
11/03/2005US20050245502 Treatments for viral infections
11/03/2005US20050245501 Succinoylamino lactams as inhibitors of A-beta protein production
11/03/2005US20050245500 Beta-ketoamide compounds with MCH antagonistic activity
11/03/2005US20050245499 Heterocyclic protein kinase inhibitors and uses thereof
11/03/2005US20050245498 Sterically-awkward beta-lactamase inhibitors
11/03/2005US20050245497 Treatment of ophthalmic conditions
11/03/2005US20050245496 Mixture with carrier; dosage units; prevent ovulation; immonomoderator
11/03/2005US20050245494 Methods to treat one or all of the defined etiologies of female sexual dysfunction
11/03/2005US20050245493 Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
11/03/2005US20050245492 Use of equol for treating skin diseases
11/03/2005US20050245491 Tetracycline derivatives and methods of use thereof
11/03/2005US20050245490 Chromene-containing compounds with anti-tubulin and vascular targeting activity
11/03/2005US20050245489 Chromene-containing compounds with anti-tubulin and vascular targeting activity
11/03/2005US20050245488 Pharmaceutically active compounds and methods of use thereof
11/03/2005US20050245487 Mitochondrially targeted antioxidants
11/03/2005US20050245486 Prostate specific membrane antigen (PSMA); for diagnosis, detection and treatment of cancer; gene overexpression; kits
11/03/2005US20050245485 Novel indole derivatives as selective androgen receptor modulators (SARMS)
11/03/2005US20050245484 Lubricious germicidal ophthalmic solutions
11/03/2005US20050245483 Matrix for sustained, invariant and independent release of active compounds
11/03/2005US20050245482 Chitosan and method of preparing chitosan
11/03/2005US20050245481 Method of producing teicoplanin
11/03/2005US20050245480 Methods of using beta glucan as a radioprotective agent
11/03/2005US20050245479 Myeloglycan
11/03/2005US20050245478 Oral administration of UFT (a combination of tegafur and uracil at a ratio of 1:4) to a postoperative lung cancer patient in need thereof for a period of at least about two years
11/03/2005US20050245477 Immunomodulatory oligonucleotides
11/03/2005US20050245472 Engineered rnai adenovirus silencing expression (erase) of dna reair proteins
11/03/2005US20050245471 Combination products for use in antitumoral treatment
11/03/2005US20050245470 Anticancer biangeloyl saponins
11/03/2005US20050245469 Crystal forms of azithromycin
11/03/2005US20050245468 Anthelmintic composition
11/03/2005US20050245467 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
11/03/2005US20050245466 Use of topoisomerase inhibitors and heat shock protein 90 inhibitors for use in chemotherapy
11/03/2005US20050245465 Compounds for treating Alzheimer's disease and for inhibiting beta-amyloid peptitde production
11/03/2005US20050245464 Use of lipid conjugates in the treatment of diseases
11/03/2005US20050245463 Novel antiretroviral sulfolipids extracted from spirulinae, method for obtaining same, compositions containing same and use thereof as inhibitors of the hiv virus reverse transcriptase
11/03/2005US20050245462 Treatment of cancer with 2-deoxyglucose
11/03/2005US20050245461 Methods for treating alcoholism
11/03/2005US20050245460 Methods and compositions for the treatment of epilepsy, seizure disorders, and other CNS disorders
11/03/2005US20050245459 Method of utilizing physiological activity of rare saccharide and composition containing rare saccharide
11/03/2005US20050245456 Combination therapy to prevent and treat diarrhea induced by cancer treatment
11/03/2005US20050245440 Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2
11/03/2005US20050245439 Prevention of joint destruction
11/03/2005US20050245433 administering encapsulated cysteamine compound to treat hypercholesterolemia, non-insulin dependent diabetes; lowering uric acid levels
11/03/2005US20050244965 culturing with an effective amount of granulocyte-macrophage colony stimulating factor, using brain tissue cells; transplantation; treating multiple sclerosis demyelination
11/03/2005US20050244914 Methods for identifying compounds for inhibition of neoplastic lesions, and pharmaceutical compositions containing such compounds
11/03/2005US20050244896 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
11/03/2005US20050244894 Modulators of paraptosis and related methods
11/03/2005US20050244826 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or wnt
11/03/2005US20050244817 Mammalian genes involved in viral infection and tumor suppression
11/03/2005US20050244816 Immunoassays, haptens, immunogens and antibodies for anti-HIV therapeutics
11/03/2005US20050244812 Kits and methods for detection of apoptotic cells
11/03/2005US20050244525 with excipient, and substantially free of alpha-unsaturated gamma-lactone; antiinflammatory
11/03/2005US20050244522 Permeation enhancer comprising genus Curcuma or germacrone for transdermal and topical administration of active agents
11/03/2005US20050244520 Topical menthol, or a related cooling compound, to induce lubrication
11/03/2005US20050244519 Bulking agent compositions
11/03/2005US20050244518 Including unique combination of fruits, vegetables, herbs, and optionally vitamins, minerals, and specialty ingredients such as bioflavonoids, lycopene, lutein, for decreasing free radical damage
11/03/2005US20050244517 Combination of proton pump inhibitor and sleep aid
11/03/2005US20050244515 Anti-microbial agent and anti-microbial composition
11/03/2005US20050244514 Flavone and adenosine from Ixeris Sonchifolia Hance is more stable in the lyophilized powder form than in liquid form for injection so that it is easy to control the quality of the product so as to make the medicament safe and effective
11/03/2005US20050244511 Adding an EDTA/NaOH mixture to acontainer and subsequently adding at least one metal compound; adding Na2SeO3 to the container to obtain the trace element solution; improve the trace mineral status of an animal
11/03/2005US20050244510 Compositions for improving mental performance
11/03/2005US20050244509 Ophthalmic solutions
11/03/2005US20050244506 Extruding mixture of alpha-2 adrenergic receptor agonist (brimonidine) and biodegradable polylactide
11/03/2005US20050244503 Small-particle pharmaceutical formulations of antiseizure and antidementia agents and immunosuppressive agents
1 ... 4481 4482 4483 4484 4485 4486 4487 4488 4489 4490 4491 4492 4493 4494 4495 4496 4497 4498 4499 4500 4501 ... 7860